Cluster Analysis According to Immunohistochemistry is a Robust Tool for Non–Small Cell Lung Cancer and Reveals a Distinct, Immune Signature-defined Subgroup
This study shows that clustering analysis is a useful tool for verifying established characteristics and generating new insights for NSCLC. Importantly, for one “immune signature” cluster, the signature of the TIL (especially the amount of CD8+ TIL) was more crucial than the histologic or any other phenotypical aspect. This may be an important finding toward explaining why only a fraction of eligible patients respond to immunomodulating anticancer therapies.
Source: Applied Immunohistochemistry and Molecular Morphology - Category: Chemistry Tags: Research Articles Source Type: research
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Chemistry | Genetics | Lung Cancer | Lymphoma | Non-Small Cell Lung Cancer | Squamous Cell Carcinoma | Study